Patten Group Inc. Has $772,000 Holdings in GE HealthCare Technologies Inc. $GEHC

Patten Group Inc. lifted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2.7% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 10,416 shares of the company’s stock after purchasing an additional 271 shares during the period. Patten Group Inc.’s holdings in GE HealthCare Technologies were worth $772,000 as of its most recent filing with the SEC.

Other hedge funds also recently modified their holdings of the company. N.E.W. Advisory Services LLC acquired a new position in shares of GE HealthCare Technologies during the first quarter worth $25,000. Bogart Wealth LLC lifted its holdings in shares of GE HealthCare Technologies by 260.0% during the first quarter. Bogart Wealth LLC now owns 342 shares of the company’s stock worth $28,000 after purchasing an additional 247 shares during the period. Stonebridge Financial Group LLC lifted its holdings in shares of GE HealthCare Technologies by 165.7% during the first quarter. Stonebridge Financial Group LLC now owns 356 shares of the company’s stock worth $29,000 after purchasing an additional 222 shares during the period. Olde Wealth Management LLC acquired a new position in shares of GE HealthCare Technologies during the first quarter worth $35,000. Finally, Gladwyn Financial Advisors Inc. acquired a new position in shares of GE HealthCare Technologies during the second quarter worth $34,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Up 0.1%

GEHC opened at $76.14 on Thursday. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $94.80. The company has a current ratio of 1.16, a quick ratio of 0.93 and a debt-to-equity ratio of 0.85. The company has a market cap of $34.76 billion, a P/E ratio of 15.60, a price-to-earnings-growth ratio of 2.91 and a beta of 1.13. The company has a fifty day moving average price of $74.61 and a two-hundred day moving average price of $72.19.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, beating the consensus estimate of $0.91 by $0.15. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The firm had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.96 billion. During the same period in the previous year, the firm posted $1.00 earnings per share. The business’s revenue was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 24th will be paid a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Friday, October 24th. GE HealthCare Technologies’s payout ratio is 2.87%.

Analyst Ratings Changes

GEHC has been the topic of a number of recent research reports. Citigroup lowered shares of GE HealthCare Technologies from a “buy” rating to a “neutral” rating and cut their price target for the stock from $93.00 to $83.00 in a report on Tuesday, October 7th. Wall Street Zen lowered shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, September 20th. Zacks Research lowered shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, September 29th. BTIG Research boosted their target price on shares of GE HealthCare Technologies from $87.00 to $89.00 and gave the company a “buy” rating in a report on Monday, October 13th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Tuesday, October 14th. Six investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $85.20.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.